Macitentan and morbidity and mortality in pulmonary arterial hypertension.

By T. Pulido, I. Adzerikho, R. Channick, M. Delcroix, N. Galiè, H. Ghofrani, P. Jansa, Z. Jing, F. Brun, S. Mehta and 9 more. New England Journal of Medicine, 2013

1,290 citations recorded by the source corpus.

Subfields: Complementary and alternative medicine, Pulmonary and Respiratory Medicine

View Paper: https://www.semanticscholar.org/paper/6b37fab87c630b495376ddb874b49e135b0d3da0

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

1. O. Kowal-Bielecka
2. J. Fransen
3. J. Avouac
4. M. Becker
5. A. Kułak
6. D. Khanna
7. Y. Allanore
8. O. Distler

Citations in the corpus

• Update of EULAR recommendations for the treatment of systemic sclerosis (2015, background): “As discussed in previous paragraph, this approach is in line with recently published guidelines regarding management of PAH in general, and seems particularly important in patients with SSc-PAH known to have more progressive disease than patients with other forms of PAH.”